Resveratrol corrects aberrant splicing of RYR1 pre-mRNA and Ca2+ signal in myotonic dystrophy type 1 myotubes

Resveratrol corrects aberrant splicing of RYR1 pre-mRNA and Ca2+ signal in myotonic dystrophy type 1 myotubes

Myotonic dystrophy type 1 (DM1) is a spliceopathy related to the mis-splicing of several genes caused by sequestration of nuclear transcriptional RNA-binding factors from non-coding CUG repeats of DMPK pre-mRNAs. Dysregulation of ryanodine receptor 1 (RYR1), sarcoplasmatic/endoplasmatic Ca2+-ATPase...

Full description

Bibliographic Details
Main Authors:	Massimo Santoro, Roberto Piacentini, Alessia Perna, Eugenia Pisano, Anna Severino, Anna Modoni, Claudio Grassi, Gabriella Silvestri
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2020-01-01
Series:	Neural Regeneration Research
Subjects:	alternative splicing; calcium homeostasis; cug-bp1; foci; mbnl1; myotonic dystrophy type 1; myotubes; resveratrol
Online Access:	http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=9;spage=1757;epage=1766;aulast=Santoro

Similar Items

Zebrafish mbnl mutants model physical and molecular phenotypes of myotonic dystrophy
by: Melissa N. Hinman, et al.
Published: (2021-06-01)

Muscleblind-like1 undergoes ectopic relocation in the nuclei of skeletal muscles in myotonic dystrophy and sarcopenia
by: M. Malatesta, et al.
Published: (2013-04-01)

RNAi Screening of the Kinome Identifies PACT as a Novel Genetic Modifier of Foci Integrity in Myotonic Dystrophy type 1
by: O'Reilly, Sean W.P.
Published: (2014)

RNAi Screening of the Kinome Identifies PACT as a Novel Genetic Modifier of Foci Integrity in Myotonic Dystrophy type 1
by: O'Reilly, Sean W.P.
Published: (2014)

An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I
by: Andrea López-Martínez, et al.
Published: (2020-09-01)

Analysis and Modulation of PACT, DICER and MBNL1 in the Context of Myotonic Dystrophy Type I
by: Azimi, Mehrdad
Published: (2016)

Short Tandem Repeat Expansions and RNA-Mediated Pathogenesis in Myotonic Dystrophy
by: Łukasz J. Sznajder, et al.
Published: (2019-07-01)

Splicing of human chloride channel 1
by: Takumi Nakamura, et al.
Published: (2016-03-01)

Targeting Myotonic Dystrophy with Small Molecules
by: Coonrod, Leslie, et al.
Published: (2012)

Mécanismes moléculaires associés aux changements d'épissage de Tau dans une Tauopathie, la dystrophie myotonique de type 1
by: Tran-Ladam, Hélène
Published: (2010)

Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1
by: Stefan Hintze, et al.
Published: (2018-10-01)

Proteome profile in Myotonic Dystrophy type 2 myotubes reveals dysfunction in protein processing and mitochondrial pathways
by: Francesco Rusconi, et al.
Published: (2010-05-01)

Generation and Neuronal Differentiation of hiPSCs From Patients With Myotonic Dystrophy Type 2
by: Paola Spitalieri, et al.
Published: (2018-07-01)

Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy
by: Estefanía Cerro-Herreros, et al.
Published: (2021-12-01)

Altered levels of the splicing factor muscleblind modifies cerebral cortical function in mouse models of myotonic dystrophy
by: Gang Chen, et al.
Published: (2018-04-01)

LDB3 splicing abnormalities are specific to skeletal muscles of patients with myotonic dystrophy type 1 and alter its PKC binding affinity
by: Yoshihiro Yamashita, et al.
Published: (2014-09-01)

MicroRNA-Based Therapeutic Perspectives in Myotonic Dystrophy
by: Arturo López Castel, et al.
Published: (2019-11-01)

Transcriptome Analysis Reveals Altered Inflammatory Pathway in an Inducible Glial Cell Model of Myotonic Dystrophy Type 1
by: Cuauhtli N. Azotla-Vilchis, et al.
Published: (2021-01-01)

Circulating Irisin Is Reduced in Male Patients with Type 1 and Type 2 Myotonic Dystrophies
by: Elena Dozio, et al.
Published: (2017-11-01)

MBNL1-Associated Mitochondrial Dysfunction and Apoptosis in C2C12 Myotubes and Mouse Skeletal Muscle
by: Shingo Yokoyama, et al.
Published: (2020-09-01)

Identification of transcripts regulated by CUG-BP, Elav-like family member 1 (CELF1) in primary embryonic cardiomyocytes by RNA-seq
by: Yotam Blech-Hermoni, et al.
Published: (2015-12-01)

A Patient with Myotonic Dystrophy Type 1 Presenting as Parkinsonism
by: Ji-Hyun Choi, et al.
Published: (2018-09-01)

Mise en place, caractérisation phénotypique et transcriptomique d'un modèle de Drosophilie de la Dystrophie Myotonique de type 1
by: Picchio, Lucie
Published: (2013)

Investigating the RNA Binding Domains of MBNL1 and the Alternative Splicing Motifs They Recognize
by: Purcell, Jamie, et al.
Published: (2012)

Editorial: Myotonic Dystrophies: Developments in Research From Bench to Bedside
by: Gabriella Silvestri, et al.
Published: (2020-09-01)

Transcriptional changes and developmental abnormalities in a zebrafish model of myotonic dystrophy type 1
by: Peter K. Todd, et al.
Published: (2014-01-01)

Mécanismes moléculaires associés aux changements d'épissage de Tau dans une Tauopathie, la dystrophie myotonique de type 1
by: Tran, Hélène
Published: (2010)

Myotonic Dystrophy Type 1 with Syringomyelia in a Young Patient
by: Xiao-Lin Yu, et al.
Published: (2016-01-01)

N-acetyl-L-cysteine Prevents Lactate-Mediated PGC1-alpha Expression in C2C12 Myotubes
by: Minas Nalbandian, et al.
Published: (2019-06-01)

Small Molecules Which Improve Pathogenesis of Myotonic Dystrophy Type 1
by: Marta López-Morató, et al.
Published: (2018-05-01)

Abnormal Cortical Thickness Is Associated With Deficits in Social Cognition in Patients With Myotonic Dystrophy Type 1
by: Laura Serra, et al.
Published: (2020-02-01)

Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling
by: Xiang Ding, et al.
Published: (2021-01-01)

Approches globales afin d’élucider les mécanismes pathogéniques de la dystrophie myotonique de type 1
by: Nguyen, Xuan-Tam
Published: (2017)

miR-30-5p Regulates Muscle Differentiation and Alternative Splicing of Muscle-Related Genes by Targeting MBNL
by: Bo-Wen Zhang, et al.
Published: (2016-01-01)

Inhibition of Postn Rescues Myogenesis Defects in Myotonic Dystrophy Type 1 Myoblast Model
by: Xiaopeng Shen, et al.
Published: (2021-08-01)

Imaging in Myotonic Dystrophy Type 1 – Case Reports
by: Jurgen Bielen, et al.
Published: (2016-10-01)

Ginsenoside Rg1 from Panax ginseng enhances myoblast differentiation and myotube growth
by: Ga-Yeon Go, et al.
Published: (2017-10-01)

Molecular genetics of congenital myotonic dystrophy
by: Stella Lanni, et al.
Published: (2019-12-01)

Studies on the functional role of phospholipid flippase in myotube formation
by: Tsuchiya, Masaki
Published: (2018)

Metabolic Alterations in Myotonic Dystrophy Type 1 and Their Correlation with Lipin
by: Tiago Mateus, et al.
Published: (2021-02-01)